Medicine Man Technologies (OTC:SHWZ – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Benchmark in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $2.50 target price on the stock.
Medicine Man Technologies Stock Performance
Featured Articles
- Five stocks we like better than Medicine Man Technologies
- What is the Australian Securities Exchange (ASX)
- This Walmart Rally has Legs: 20% Upside Left To Go
- What is the FTSE 100 index?
- 5 Companies Leading the Charge With Robotic Solutions
- How Technical Indicators Can Help You Find Oversold Stocks
- These 5 Penny Stocks Just Surged Double Digits
Receive News & Ratings for Medicine Man Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicine Man Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
